Delivery Order SPE2DB22D3016-SPE2DB25FBKN6
- Not listed
- On September 12, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,544.19 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units). The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be completed by September 15, 2025, at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $1,796.20. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, representing a single-transaction purchase of pharmaceutical inventory. The contract was competitively awarded without set-aside designation, leveraging...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,064.45 for OxyContin tablets (40mg) by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger contract vehicle with the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 28, 2025, for OxyContin ER 80 mg tablets (100 count) valued at $3,061.72. This firm fixed-price delivery order, with an ultimate completion date of May 29, 2025, represents a competitively awarded contract with no set-aside designation. The award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,112.81 for OxyContin ER 20 mg tablets (100-count supply) on September 15, 2025, with completion targeted for September 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX)...
- The Defense Logistics Agency awarded a delivery order valued at $3,009.06 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,184.84 and is structured as a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $6,542.62 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 80 mg tablets (100-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a contract value of $2,783.05. This delivery order represents a firm fixed price, non-set-aside competitive award supporting federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKN6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of OxyContin ER 80 mg tablets (100-count packages) valued at $2,026.26. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military healthcare programs and the Defense Health Agency. The company's federal contract performance demonstrates its capability to reliably deliver controlled pharmaceuticals and other critical medical commodities through the DLA's supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/22/25 |